Timosaponin AIII alleviates type 2 diabetes-induced cardiomyopathy by targeting galectin-3 (LGALS3)

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 9615407bfc31eb21-LAX IP: 118.31.43.22 UTC time: 2025-07-18T22:00:26+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

Comments (0)

No login
gif